The CD4/CD8-ratio of tumor infiltrating lymphocytes possesses in some malignancies—like gastric cancer [31] or as previously mentioned in the triple negative breast carcinoma [10]—a predictive value. This evidence concerns the gene CD4 and triple-negative breast carcinoma.